This brand name is authorized in Hong Kong, New Zealand, Singapore
The drug DECOZOL contains one active pharmaceutical ingredient (API):
|
1
Miconazole
UNII 7NNO0D7S5M - MICONAZOLE
|
|
Miconazole possesses an antifungal activity against the common dermatophytes and yeasts as well as an antibacterial activity against certain gram-positive bacilli and cocci. Its activity is based on the inhibition of the ergosterol biosynthesis in fungi and the change in the composition of the lipid components in the membrane, resulting in fungal cell necrosis. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| A01AB | Antiinfectives and antiseptics for local oral treatment | A Alimentary tract and metabolism → A01 Stomatological preparations → A01A Stomatological preparations |
| D01AC02 | Miconazole | D Dermatologicals → D01 Antifungals for dermatological use → D01A Antifungals for topical use → D01AC Imidazole and triazole derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: HK | Department of Health Drug Office | Identifier(s): 45780 |
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 13600 |
| Country: SG | Health Sciences Authority | Identifier(s): 10561P, 14334P |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
